3Grimwade D,Lo Coco F.Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia[].Leukemia.2002
4Grimwade D.The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease[].British Journal of Haematology.1999
5Redner RL.Variations on a theme: the alternate translocations in APL[].Leukemia.2002
6Stamatorynnophoulos G,Majerus PM,Perlmutter RM, et al.The molecular basis of blood diseases[]..2000
7Collins,SJ.The role of retinoids and retinoic acid receptors in normal hematopoiesis[].Leukemia.2002
8Hoffman R,Benz E J,Shattil S.J,et al.Hematology:basic princi-ples and practice[]..2000
9Ferbeyre,G.PML a target of translocations in APL is a regulator of cellular senescence[].Leukemia.2002
10Strudwick S,Borden KLB.Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities[].Leukemia.2002
二级参考文献5
1Mayer R J, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med, 1994, 331 (14):896-903.
2Cammagi CM, Strocchi E, Carisi P, et al. Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study. Can Chem Pharm,1992, 30 (4): 307-316.
3Xiao-Jun Huang,Peter H Wiernik,Robert S Klein,Robert E Gallagher MD. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases[J] 1999,Medical Oncology(1):58～64
